WellDyneRx, an independent Pharmacy Benefit Manager involved in delivering solutions through integrated data and technology, has named Jeff Park as its new chairman and chief executive officer of the company, it was reported yesterday.
Park is the former executive vice president and chief operating officer of Catamaran, which is now called optumRx. During his tenure, Catamaran grew from USD55m in revenues to a Fortune 500 public company with over USD21bn in revenues before it was acquired by United Health Group in 2015.
WellDyneRx lead director, Eric Elliott, said, 'We are excited to have Jeff join WellDyneRx president, Zach Johnson, and the rest of our leadership team. Jeff's strategic vision and operating expertise support our growth plans. Our extensive search for the right executive produced a great result. Now, with a strong team in place, we expect our value proposition in the constantly changing PBM sector to resonate even more clearly, and growth will accelerate.'
Inspiration Healthcare secures US purchasing agreement to drive Airon growth
West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m
Citius Pharmaceuticals reports full-year financial results
Sanofi receives FDA complete response letter for tolebrutinib in progressive MS
Amgen announces Q1 2026 dividend
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera